Abstract
Objective: With increasing maternal antiretroviral treatment (ART), the number of children newly infected withHIVhas declined. However, the possible increased mortality in the large number ofHIV‐exposed, uninfected (HEU) children may be of concern. We quantified mortality risks amongHEUchildren and reviewed associated factors.Methods: Systematic search of electronic databases (PubMed, Scopus). We included all studies reporting mortality ofHEUchildren to age 60 months and associated factors. Relative risk of mortality betweenHEUandHIV‐unexposed, uninfected (HUU) children was extracted where relevant. Inverse variance methods were used to adjust for study size. Random‐effects models were fitted to obtain pooled estimates.Results: A total of 14 studies were included in the meta‐analysis and 13 in the review of associated factors. The pooled cumulative mortality inHEUchildren was 5.5% (95%CI: 4.0–7.2;I2= 94%) at 12 months (11 studies) and 11.0% (95%CI: 7.6–15.0;I2= 93%) at 24 months (four studies). The pooled risk ratios for the mortality inHEUchildren compared toHUUchildren in the same setting were 1.9 (95%CI: 0.9–3.8;I2= 93%) at 12 months (four studies) and 2.4 (95%CI: 1.1–5.1;I2= 93%) at 24 months (three studies).Conclusion: Compared toHUUchildren, mortality risk inHEUchildren was about double at both age points, although the association was not statistically significant at 12 months. Interpretation of the pooled estimates is confounded by considerable heterogeneity between studies. Further research is needed to characterise the impact of maternal death and breastfeeding on the survival ofHEUinfants in the context of maternalART, where current evidence is limited.
Funding Information
  • World Health Organization

This publication has 40 references indexed in Scilit: